Company profile for Lepu Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lepu Bio was established in January 2018 by Dr. Pu Zhongjie, the founder of Lepu Medical. It is an innovation-driven biopharmaceutical company based in China and facing the world. With the mission of solving unmet clinical needs, it focuses on tumor immunotherapy and Research and development, production and sales of targeted therapy drugs. The company has a whole industry chain system covering the screening and optimization of...
Lepu Bio was established in January 2018 by Dr. Pu Zhongjie, the founder of Lepu Medical. It is an innovation-driven biopharmaceutical company based in China and facing the world. With the mission of solving unmet clinical needs, it focuses on tumor immunotherapy and Research and development, production and sales of targeted therapy drugs. The company has a whole industry chain system covering the screening and optimization of innovative drugs, global clinical research and development, large-scale production and commercialization, and has strong transformation and industrialization capabilities from core technologies to finished drugs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
3rd Floor, Building 41, No. 258, Xinzhuan Road, Xinqiao Town, Shanghai, Shangh...
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/biodlink-and-lepu-biopharma-celebrate-successful-launch-of-the-worlds-first-egfr-targeting-adc-drug-marking-a-major-milestone-in-mutual-collaboration-in-biologics-cmc-302623064.html

PR NEWSWIRE BIO
21 Nov 2025

https://www.prnewswire.com/news-releases/biodlink-congratulates-lepu-biopharma-on-securing-approval-for-the-worlds-first-approved-egfr-targeted-adc-302605438.html

PR NEWSWIRE
05 Nov 2025

https://www.fiercebiotech.com/biotech/lepu-biopharma-supplies-two-t-cell-engagers-new-caribbean-company-857m-deal

FIERCE BIOTECH
02 Aug 2025

https://ir.arrivent.com/news-releases/news-release-details/arrivent-biopharma-enters-exclusive-license-lepu-biopharma

PRESS RELEASE
22 Jan 2025

https://www.prnewswire.com/news-releases/dp-technology-and-lepu-biopharma-announce-milestone-collaboration-leveraging-advanced-computational-methods-to-accelerate-adc-drug-innovation-302312430.html

PR NEWSWIRE
21 Nov 2024

https://www.contractpharma.com/contents/view_breaking-news/2023-02-23/keymed-lepu-biopharma-enter-global-license-agreement-with-astrazeneca-for-cmg901/?widget=listSection

CONTRACT PHARMA
23 Feb 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty